| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADEVO: Proof-of-concept of adenovirus-directed EVOlution by random peptide display on the fiber knob
|
Sallard, Erwan
|
|
|
32 |
4 |
p.
|
artikel
|
| 2 |
An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting
|
Wienen, Frederik
|
|
|
32 |
4 |
p.
|
artikel
|
| 3 |
A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacy
|
Wenes, Mathias
|
|
|
32 |
4 |
p.
|
artikel
|
| 4 |
APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy
|
Swanson, Jack
|
|
|
32 |
4 |
p.
|
artikel
|
| 5 |
AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer
|
Yu, Jianlei
|
|
|
32 |
4 |
p.
|
artikel
|
| 6 |
Bile molecular landscape provides pathological insight and classifies signatures predictive of carcinoma of the gall bladder
|
Sharma, Nupur
|
|
|
32 |
4 |
p.
|
artikel
|
| 7 |
Bridging the antigen-presentation gap for adoptive cell therapies
|
Hont, Amy B.
|
|
|
32 |
4 |
p.
|
artikel
|
| 8 |
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity
|
van Vliet, Amanda A.
|
|
|
32 |
4 |
p.
|
artikel
|
| 9 |
CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer
|
Duan, Zhijian
|
|
|
32 |
4 |
p.
|
artikel
|
| 10 |
CAR-T cell therapy: Advances in digestive system malignant tumors
|
Xu, Nan
|
|
|
32 |
4 |
p.
|
artikel
|
| 11 |
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
|
Montero-Hidalgo, Antonio J.
|
|
|
32 |
4 |
p.
|
artikel
|
| 12 |
Combination therapy of bevacizumab and galunisertib extends TVN time window
|
Yin, Ling
|
|
|
32 |
4 |
p.
|
artikel
|
| 13 |
Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma
|
Luo, Wen
|
|
|
32 |
4 |
p.
|
artikel
|
| 14 |
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer
|
Matthews, Bayley
|
|
|
32 |
4 |
p.
|
artikel
|
| 15 |
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma
|
Khurshid, Safiya
|
|
|
32 |
4 |
p.
|
artikel
|
| 16 |
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade
|
Tesfay, Mulu Z.
|
|
|
32 |
4 |
p.
|
artikel
|
| 17 |
Exploring prognostic implications of miRNA signatures and telomere maintenance genes in kidney cancer
|
Yerukala Sathipati, Srinivasulu
|
|
|
32 |
4 |
p.
|
artikel
|
| 18 |
FOS+ B cells: Key mediators of immunotherapy resistance in diverse cancer types
|
Zhang, Xiangyang
|
|
|
32 |
4 |
p.
|
artikel
|
| 19 |
Genetically stable multi-gene edited iPSCs-derived NK cells for enhanced cancer immunotherapy
|
Kwon, Daekee
|
|
|
32 |
4 |
p.
|
artikel
|
| 20 |
Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – targeting of p300-proficient and -deficient cancers
|
Gronkowska, Karolina
|
|
|
32 |
4 |
p.
|
artikel
|
| 21 |
Getting the job done right requires the right tools: Increased CAR T cell efficiency with improved packaging cell line
|
Mathieu, Sarah
|
|
|
32 |
4 |
p.
|
artikel
|
| 22 |
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer
|
Rosewell Shaw, Amanda
|
|
|
32 |
4 |
p.
|
artikel
|
| 23 |
Innovative approaches to glioma treatment: Oncolytic foamy virus and CAR T cell therapy
|
Amhis, Nawal
|
|
|
32 |
4 |
p.
|
artikel
|
| 24 |
Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects
|
Ishibashi, Airi
|
|
|
32 |
4 |
p.
|
artikel
|
| 25 |
Mesenchymal stem cell origin contributes to the antitumor effect of oncolytic virus carriers
|
Sukegawa, Makoto
|
|
|
32 |
4 |
p.
|
artikel
|
| 26 |
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responses
|
Piki, Emilia
|
|
|
32 |
4 |
p.
|
artikel
|
| 27 |
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer
|
Lin, Heather K.
|
|
|
32 |
4 |
p.
|
artikel
|
| 28 |
Newcastle disease virus harboring the PTEN gene inhibits pancreatic cancer growth by inhibiting PI3K/AKT/mTOR signaling and activating apoptosis
|
Kim, Seonhee
|
|
|
32 |
4 |
p.
|
artikel
|
| 29 |
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity
|
Hirigoyen, Ugo
|
|
|
32 |
4 |
p.
|
artikel
|
| 30 |
Optimized protocol for culturing menstrual blood-derived MSCs for combination with oncolytic adenoviruses in cancer treatment
|
Costa-Garcia, Marcel
|
|
|
32 |
4 |
p.
|
artikel
|
| 31 |
Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand
|
Luanpitpong, Sudjit
|
|
|
32 |
4 |
p.
|
artikel
|
| 32 |
Retraction Notice to: MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells
|
Xie, Binhui
|
|
|
32 |
4 |
p.
|
artikel
|
| 33 |
Senescence-associated secretory phenotype regulation by dual-drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy
|
Prakash, Ajay
|
|
|
32 |
4 |
p.
|
artikel
|
| 34 |
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1
|
Luo, Yan
|
|
|
32 |
4 |
p.
|
artikel
|
| 35 |
Stratifying hepatocellular carcinoma based on immunophenotypes for immunotherapy response and prognosis
|
Liu, Yunpeng
|
|
|
32 |
4 |
p.
|
artikel
|
| 36 |
Targeting cancer stem cells by TPA leads to inhibition of refractory sarcoma and extended overall survival
|
Galoian, Karina
|
|
|
32 |
4 |
p.
|
artikel
|
| 37 |
Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy
|
Filippopoulou, Chrysa
|
|
|
32 |
4 |
p.
|
artikel
|
| 38 |
Thank you to our 2024 reviewers
|
|
|
|
32 |
4 |
p.
|
artikel
|
| 39 |
The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression
|
Park, Soyoung
|
|
|
32 |
4 |
p.
|
artikel
|
| 40 |
The YAP1-MAML2 fusion drives tumorigenesis and sustains tumor growth
|
Ni, Wei
|
|
|
32 |
4 |
p.
|
artikel
|
| 41 |
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma
|
Ringwalt, Emily M.
|
|
|
32 |
4 |
p.
|
artikel
|
| 42 |
Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy
|
Baracuhy, Enzo Mongiovi
|
|
|
32 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving